{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T14:57:20Z","timestamp":1794927440951,"version":"4.9.1"},"reference-count":221,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T00:00:00Z","timestamp":1716595200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.ymgme.2024.108507","type":"journal-article","created":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T23:26:42Z","timestamp":1716593202000},"page":"108507","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Causes of death in mucopolysaccharidoses"],"prefix":"10.1016","volume":"142","author":[{"given":"Estera","family":"Rintz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin","family":"Banacki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja","family":"Ziemian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Kobus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grzegorz","family":"Wegrzyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ymgme.2024.108507_bb0005","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s13353-022-00703-1","article-title":"Misdiagnosis in mucopolysaccharidoses","volume":"63","author":"Wi\u015bniewska","year":"2022","journal-title":"J. Appl. Genet."},{"issue":"1","key":"10.1016\/j.ymgme.2024.108507_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5582\/irdr.2020.01011","article-title":"A basic understanding of mucopolysaccharidosis: incidence, clinical features, diagnosis, and management","volume":"9","author":"Zhou","year":"2020","journal-title":"Intractable Rare Dis Res."},{"issue":"17","key":"10.1016\/j.ymgme.2024.108507_bb0015","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.1042\/BCJ20200546","article-title":"Arylsulfatase K inactivation causes mucopolysaccharidosis due to deficient glucuronate desulfation of heparan and chondroitin sulfate","volume":"477","author":"Trabszo","year":"2020","journal-title":"Biochem. J."},{"issue":"11","key":"10.1016\/j.ymgme.2024.108507_bb0020","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1007\/s00439-022-02441-0","article-title":"Usher syndrome type IV: clinically and molecularly confirmed by novel ARSG variants","volume":"141","author":"Velde","year":"2022","journal-title":"Hum. Genet."},{"issue":"1","key":"10.1016\/j.ymgme.2024.108507_bb0025","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1186\/s13023-019-1232-0","article-title":"The attenuated end of the phenotypic spectrum in MPS III: from late-onset stable cognitive impairment to a non-neuronopathic phenotype","volume":"14","author":"Nijmeijer","year":"2019","journal-title":"Orphanet J. Rare Dis."},{"issue":"1","key":"10.1016\/j.ymgme.2024.108507_bb0030","doi-asserted-by":"crossref","first-page":"66","DOI":"10.4103\/0976-237X.79287","article-title":"Mucopolysaccharidosis type I hurler-Scheie syndrome: a rare case report","volume":"2","author":"Tatapudi","year":"2011","journal-title":"Contemp Clin Dent."},{"issue":"3","key":"10.1016\/j.ymgme.2024.108507_bb0035","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3390\/diagnostics10030161","article-title":"Mucopolysaccharidosis type I","volume":"10","author":"Kubaski","year":"2020","journal-title":"Diagnostics (Basel)."},{"issue":"8","key":"10.1016\/j.ymgme.2024.108507_bb0040","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.3390\/cells9081838","article-title":"Mucopolysaccharidosis type I: a review of the natural history and molecular pathology","volume":"9","author":"Hampe","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.ymgme.2024.108507_bb0045","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.783644","article-title":"Mucopolysaccharidosis type I in the Russian Federation and other republics of the former Soviet Union: molecular genetic analysis and epidemiology","volume":"8","author":"Voskoboeva","year":"2022","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.ymgme.2024.108507_bb0050","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1750-1172-3-24","article-title":"The prevalence of and survival in Mucopolysaccharidosis I: hurler, hurler-Scheie and Scheie syndromes in the UK","volume":"3","author":"Moore","year":"2008","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2024.108507_bb0055","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s13353-014-0262-5","article-title":"Prevalence rates of mucopolysaccharidoses in Poland","volume":"56","author":"Jurecka","year":"2015","journal-title":"J. Appl. Genet."},{"key":"10.1016\/j.ymgme.2024.108507_bb0060","series-title":"GeneReviews [Internet]","author":"Clarke","year":"2002"},{"issue":"8","key":"10.1016\/j.ymgme.2024.108507_bb0065","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.3390\/genes13081293","article-title":"Early neonatal cardiac phenotype in hurler syndrome: case report and literature review","volume":"13","author":"Pillai","year":"2022","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.ymgme.2024.108507_bb0070","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/471325","article-title":"Glycosaminoglycan storage disorders: a review","volume":"2012","author":"Coutinho","year":"2012","journal-title":"Biochem. Res. Int."},{"issue":"6","key":"10.1016\/j.ymgme.2024.108507_bb0075","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1007\/s10545-011-9359-8","article-title":"Cardiac disease in patients with mucopolysaccharidosis: presentation, diagnosis and management","volume":"34","author":"Braunlin","year":"2011","journal-title":"J. Inherit. Metab. Dis."},{"issue":"2","key":"10.1016\/j.ymgme.2024.108507_bb0080","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s10545-012-9555-1","article-title":"Respiratory and sleep disorders in mucopolysaccharidosis","volume":"36","author":"Berger","year":"2013","journal-title":"J. Inherit. Metab. Dis."},{"issue":"3","key":"10.1016\/j.ymgme.2024.108507_bb0085","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1177\/0003489414550154","article-title":"Airway-related symptoms and surgeries in patients with mucopolysaccharidosis I","volume":"124","author":"Arn","year":"2015","journal-title":"Ann. Otol. Rhinol. Laryngol."},{"issue":"2","key":"10.1016\/j.ymgme.2024.108507_bb0090","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3390\/biom11020189","article-title":"Mucopolysaccharidosis type I: current treatments, limitations, and prospects for improvement","volume":"11","author":"Hampe","year":"2021","journal-title":"Biomolecules"},{"issue":"3","key":"10.1016\/j.ymgme.2024.108507_bb0095","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.jpedsurg.2011.09.042","article-title":"High rate of postoperative mortality in patients with mucopolysaccharidosis I: findings from the MPS I registry","volume":"47","author":"Arn","year":"2012","journal-title":"J. Pediatr. Surg."},{"issue":"2","key":"10.1016\/j.ymgme.2024.108507_bb0100","first-page":"181","article-title":"Fatal disseminated adenovirus type 2 infection following bone marrow transplantation for Hurler\u2019s syndrome: a primary infection","volume":"26","author":"Morris","year":"1993","journal-title":"J. Inf. Secur."},{"issue":"6","key":"10.1016\/j.ymgme.2024.108507_bb0105","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.braindev.2019.01.008","article-title":"Early enzyme replacement therapy enables a successful hematopoietic stem cell transplantation in mucopolysaccharidosis type IH: divergent clinical outcomes in two Japanese siblings","volume":"41","author":"Yamazaki","year":"2019","journal-title":"Brain and Development"},{"issue":"1","key":"10.1016\/j.ymgme.2024.108507_bb0110","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ymgme.2008.10.009","article-title":"A dose-optimization trial of laronidase (Aldurazyme) in patients with mucopolysaccharidosis I","volume":"96","author":"Giugliani","year":"2009","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2024.108507_bb0115","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/8904_2014_395","article-title":"Long-term functional outcomes of children with hurler syndrome treated with unrelated umbilical cord blood transplantation","volume":"20","author":"Coletti","year":"2015","journal-title":"JIMD Rep."},{"issue":"3","key":"10.1016\/j.ymgme.2024.108507_bb0120","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s10545-017-0034-6","article-title":"Long term survival and cardiopulmonary outcome in children with hurler syndrome after haematopoietic stem cell transplantation","volume":"40","author":"Lum","year":"2017","journal-title":"J. Inherit. Metab. Dis."},{"issue":"7","key":"10.1016\/j.ymgme.2024.108507_bb0125","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1182\/blood.V91.7.2601","article-title":"Hurler syndrome: II. Outcome of HLA-genotypically identical sibling and HLA-haploidentical related donor bone marrow transplantation in fifty-four children. The Storage Disease Collaborative Study Group","volume":"91","author":"Peters","year":"1998","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.ymgme.2024.108507_bb0130","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.bbmt.2018.09.035","article-title":"Late mortality after allogeneic blood or marrow transplantation for inborn errors of metabolism: a report from the blood or marrow transplant survivor Study-2 (BMTSS-2)","volume":"25","author":"Wadhwa","year":"2019","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"7","key":"10.1016\/j.ymgme.2024.108507_bb0135","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1038\/bmt.2009.319","article-title":"Pre-transplant risk factors affecting outcome in hurler syndrome","volume":"45","author":"Orchard","year":"2010","journal-title":"Bone Marrow Transplant."},{"issue":"5","key":"10.1016\/j.ymgme.2024.108507_bb0140","doi-asserted-by":"crossref","first-page":"e1343","DOI":"10.1542\/peds.2009-2047","article-title":"Fatal coronary artery disease in an infant with severe mucopolysaccharidosis type I","volume":"127","author":"van den Broek","year":"2011","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.ymgme.2024.108507_bb0145","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0379-0738(95)98129-B","article-title":"Death in the bathtub involving children","volume":"72","author":"Schmidt","year":"1995","journal-title":"Forensic Sci. Int."},{"issue":"6","key":"10.1016\/j.ymgme.2024.108507_bb0150","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1007\/BF00711520","article-title":"Long-term clinical progress in bone marrow transplanted mucopolysaccharidosis type I patients with a defined genotype","volume":"16","author":"Hopwood","year":"1993","journal-title":"J. Inherit. Metab. Dis."},{"issue":"Suppl. 1","key":"10.1016\/j.ymgme.2024.108507_bb0155","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1007\/s10545-009-1057-4","article-title":"Postmortem studies on a patient with mucopolysaccharidosis type I: histopathological findings after one year of enzyme replacement therapy","volume":"32","author":"Yano","year":"2009","journal-title":"J. Inherit. Metab. Dis."},{"issue":"7","key":"10.1016\/j.ymgme.2024.108507_bb0160","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/j.1651-2227.2002.tb03330.x","article-title":"Cardiovascular changes in children with mucopolysaccharide disorders","volume":"91","author":"Mohan","year":"2002","journal-title":"Acta Paediatr."},{"issue":"12","key":"10.1016\/j.ymgme.2024.108507_bb0165","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/sj.bmt.1704105","article-title":"Outcome of 27 patients with Hurler\u2019s syndrome transplanted from either related or unrelated haematopoietic stem cell sources","volume":"31","author":"Souillet","year":"2003","journal-title":"Bone Marrow Transplant."},{"issue":"3","key":"10.1016\/j.ymgme.2024.108507_bb0170","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/MPH.0b013e3182050945","article-title":"Long-term adaptive functioning outcomes of children with inherited metabolic and genetic diseases treated with hematopoietic stem cell transplantation in a single large pediatric center: parents\u2019 perspective","volume":"33","author":"Gassas","year":"2011","journal-title":"J. Pediatr. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.ymgme.2024.108507_bb0175","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s10545-013-9630-2","article-title":"Surgical management of thoracolumbar kyphosis in mucopolysaccharidosis type 1 in a reference center","volume":"37","author":"Abelin","year":"2014","journal-title":"J. Inherit. Metab. Dis."},{"issue":"3","key":"10.1016\/j.ymgme.2024.108507_bb0180","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1517\/14656566.6.3.489","article-title":"The first 5 years of clinical experience with laronidase enzyme replacement therapy for mucopolysaccharidosis I","volume":"6","author":"Wraith","year":"2005","journal-title":"Expert. Opin. Pharmacother."},{"key":"10.1016\/j.ymgme.2024.108507_bb0185","article-title":"Enzyme replacement therapy with laronidase (Aldurazyme(\u00ae)) for treating mucopolysaccharidosis type I","volume":"4","author":"Jameson","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"issue":"3","key":"10.1016\/j.ymgme.2024.108507_bb0190","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/s41409-022-01886-1","article-title":"Long term follow-up after haematopoietic stem cell transplantation for mucopolysaccharidosis type I-H: a retrospective study of 51 patients","volume":"58","author":"Gardin","year":"2023","journal-title":"Bone Marrow Transplant."},{"issue":"1","key":"10.1016\/j.ymgme.2024.108507_bb0195","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/sj.bmt.1705401","article-title":"Haematopoietic cell transplantation (HCT) in combination with enzyme replacement therapy (ERT) in patients with hurler syndrome","volume":"38","author":"Cox-Brinkman","year":"2006","journal-title":"Bone Marrow Transplant."},{"issue":"1","key":"10.1016\/j.ymgme.2024.108507_bb0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1590\/S0004-282X2006000100001","article-title":"Bone marrow transplantation in patients with storage diseases: a developing country experience","volume":"64","author":"Lange","year":"2006","journal-title":"Arq. Neuropsiquiatr."},{"key":"10.1016\/j.ymgme.2024.108507_bb0205","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2022.877735","article-title":"The outcome of allogeneic hematopoietic stem cell transplantation from different donors in recipients with mucopolysaccharidosis","volume":"10","author":"Qu","year":"2022","journal-title":"Front. Pediatr."},{"issue":"3","key":"10.1016\/j.ymgme.2024.108507_bb0210","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.carpath.2014.01.001","article-title":"Unexpected coronary artery findings in mucopolysaccharidosis. Report of four cases and literature review","volume":"23","author":"Braunlin","year":"2014","journal-title":"Cardiovasc. Pathol."},{"issue":"3","key":"10.1016\/j.ymgme.2024.108507_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2023.107669","article-title":"Hematopoietic cell transplantation for Mucopolysaccharidosis I in the presence of decreased cardiac function","volume":"140","author":"Pillai","year":"2023","journal-title":"Mol. Genet. Metab."},{"issue":"2","key":"10.1016\/j.ymgme.2024.108507_bb0220","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ymgme.2006.08.007","article-title":"A follow-up study of MPS I patients treated with laronidase enzyme replacement therapy for 6 years","volume":"90","author":"Sifuentes","year":"2007","journal-title":"Mol. Genet. Metab."},{"issue":"6","key":"10.1016\/j.ymgme.2024.108507_bb0225","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1007\/s10545-005-0211-x","article-title":"Mucopolysaccharidosis I under enzyme replacement therapy with laronidase--a mortality case with autopsy report","volume":"28","author":"Lin","year":"2005","journal-title":"J. Inherit. Metab. Dis."},{"issue":"11","key":"10.1016\/j.ymgme.2024.108507_bb0230","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1016\/j.amjcard.2017.08.001","article-title":"Outcome of combined mitral and aortic valve replacement in adults with mucopolysaccharidosis (the hurler syndrome)","volume":"120","author":"Robinson","year":"2017","journal-title":"Am. J. Cardiol."},{"issue":"1","key":"10.1016\/j.ymgme.2024.108507_bb0235","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1542\/peds.2007-3847","article-title":"Long-term efficacy and safety of laronidase in the treatment of mucopolysaccharidosis I","volume":"123","author":"Clarke","year":"2009","journal-title":"Pediatrics"},{"issue":"12","key":"10.1016\/j.ymgme.2024.108507_bb0240","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1590\/0004-282x20160155","article-title":"Neurological outcomes after hematopoietic stem cell transplantation for cerebral X-linked adrenoleukodystrophy, late onset metachromatic leukodystrophy and hurler syndrome","volume":"74","author":"Saute","year":"2016","journal-title":"Arq. Neuropsiquiatr."},{"issue":"3","key":"10.1016\/j.ymgme.2024.108507_bb0245","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/humu.1380030316","article-title":"Mutation analysis of 19 North American mucopolysaccharidosis type I patients: identification of two additional frequent mutations","volume":"3","author":"Clarke","year":"1994","journal-title":"Hum. Mutat."},{"issue":"7","key":"10.1016\/j.ymgme.2024.108507_bb0250","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S0002-9149(03)00909-3","article-title":"Usefulness of bone marrow transplantation in the hurler syndrome","volume":"92","author":"Braunlin","year":"2003","journal-title":"Am. J. Cardiol."},{"issue":"1","key":"10.1016\/j.ymgme.2024.108507_bb0255","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13023-020-01644-w","article-title":"Long term disease burden post-transplantation: three decades of observations in 25 hurler patients successfully treated with hematopoietic stem cell transplantation (HSCT)","volume":"16","author":"Guffon","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"issue":"3","key":"10.1016\/j.ymgme.2024.108507_bb0260","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1093\/ajcp\/112.3.335","article-title":"Autopsy findings in umbilical cord blood transplant recipients","volume":"112","author":"Nuckols","year":"1999","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.ymgme.2024.108507_bb0265","first-page":"1","article-title":"Fatal and unanticipated cardiorespiratory disease in a two-year-old child with hurler syndrome following successful stem cell transplant","volume":"10","author":"Gupta","year":"2013","journal-title":"JIMD Rep."},{"issue":"1","key":"10.1016\/j.ymgme.2024.108507_bb0270","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1186\/s13023-020-01598-z","article-title":"Survival and diagnostic age of 175 Taiwanese patients with mucopolysaccharidoses (1985-2019)","volume":"15","author":"Lin","year":"2020","journal-title":"Orphanet J. Rare Dis."},{"issue":"1","key":"10.1016\/j.ymgme.2024.108507_bb0275","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13023-018-0817-3","article-title":"Beneath the floor: re-analysis of neurodevelopmental outcomes in untreated hurler syndrome","volume":"13","author":"Shapiro","year":"2018","journal-title":"Orphanet J. Rare Dis."},{"issue":"2","key":"10.1016\/j.ymgme.2024.108507_bb0280","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ymgme.2020.07.004","article-title":"The evolution of pulmonary function in childhood onset Mucopolysaccharidosis type I","volume":"132","author":"Broomfield","year":"2021","journal-title":"Mol. Genet. Metab."},{"issue":"2","key":"10.1016\/j.ymgme.2024.108507_bb0285","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/BF02338973","article-title":"A clinical trial of fibroblast transplantation for the treatment of mucopolysaccharidoses","volume":"6","author":"Gibbs","year":"1983","journal-title":"J. Inherit. Metab. Dis."},{"issue":"2","key":"10.1016\/j.ymgme.2024.108507_bb0290","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ymgme.2018.11.007","article-title":"Hematopoietic cell transplantation for severe MPS I in the first six months of life: the heart of the matter","volume":"126","author":"Braunlin","year":"2019","journal-title":"Mol. Genet. Metab."},{"issue":"5","key":"10.1016\/j.ymgme.2024.108507_bb0295","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/jnc.14632","article-title":"The role of innate immunity in mucopolysaccharide diseases","volume":"148","author":"Parker","year":"2019","journal-title":"J. Neurochem."},{"issue":"7","key":"10.1016\/j.ymgme.2024.108507_bb0300","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1073\/pnas.70.7.2134","article-title":"The defect in the Hunter syndrome: deficiency of sulfoiduronate sulfatase","volume":"70","author":"Bach","year":"1973","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ymgme.2024.108507_bb0305","series-title":"Case Reports in Otolaryngology.","first-page":"4","article-title":"Hunter syndrome diagnosed by otorhinolaryngologist","author":"Hashimoto","year":"2018"},{"key":"10.1016\/j.ymgme.2024.108507_bb0310","series-title":"Mucopolysaccharidosis Type II. [Updated 2023 Jul 25]","author":"Hashmi","year":"2023"},{"issue":"4","key":"10.1016\/j.ymgme.2024.108507_bb0315","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.pediatrneurol.2004.10.009","article-title":"Mucopolysaccharidosis type II in females: case report and review of literature","volume":"32","author":"Tuschl","year":"2005","journal-title":"Pediatr. Neurol."},{"issue":"4","key":"10.1016\/j.ymgme.2024.108507_bb0320","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s00431-012-1703-y","article-title":"Diagnosing Hunter syndrome in pediatric practice: practical considerations and common pitfalls","volume":"171","author":"Burton","year":"2012","journal-title":"Eur. J. Pediatr."},{"issue":"1","key":"10.1016\/j.ymgme.2024.108507_bb0325","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ymgme.2021.03.002","article-title":"The natural history of neurocognition in MPS disorders: a review","volume":"133","author":"Shapiro","year":"2021","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2024.108507_bb0330","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s10545-011-9378-5","article-title":"Hearing loss in patients with mucopolysaccharidosis II: data from HOS \u2013 the Hunter outcome survey","volume":"35","author":"Keilmann","year":"2012","journal-title":"J. Inherit. Metab. Dis."},{"issue":"7","key":"10.1016\/j.ymgme.2024.108507_bb0335","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/GIM.0b013e31817701e6","article-title":"HOS investigators, initial report from the Hunter outcome survey","volume":"10","author":"Wraith","year":"2008","journal-title":"Genet. Med."},{"issue":"5","key":"10.1016\/j.ymgme.2024.108507_bb0340","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/j.1525-1470.1998.tb01367.x","article-title":"Ratnakar, C, pebbling of the skin: a marker of Hunter\u2019s syndrome","volume":"15","author":"Thappa","year":"1998","journal-title":"Pediatr. Dermatol."},{"issue":"Issue suppl_5","key":"10.1016\/j.ymgme.2024.108507_bb0345","doi-asserted-by":"crossref","first-page":"v4","DOI":"10.1093\/rheumatology\/ker394","article-title":"Overview of the mucopolysaccharidoses","volume":"50","author":"Muenzer","year":"2011","journal-title":"Rheumatology"},{"issue":"2","key":"10.1016\/j.ymgme.2024.108507_bb0350","doi-asserted-by":"crossref","first-page":"e377","DOI":"10.1542\/peds.2007-1350","article-title":"Recognition and diagnosis of mucopolysaccharidosis II (Hunter syndrome)","volume":"121","author":"Martin","year":"2008","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.ymgme.2024.108507_bb0355","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00431-007-0635-4","article-title":"Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy","volume":"167","author":"Wraith","year":"2008","journal-title":"Eur. J. Pediatr."},{"issue":"4","key":"10.1016\/j.ymgme.2024.108507_bb0360","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1007\/s10545-009-1119-7","article-title":"Mortality and cause of death in mucopolysaccharidosis type II-a historical review based on data from the Hunter outcome survey (HOS)","volume":"32","author":"Jones","year":"2009","journal-title":"J. Inherit. Metab. Dis."},{"issue":"5","key":"10.1016\/j.ymgme.2024.108507_bb0365","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1055\/s-2008-1071352","article-title":"Severe type Hunter\u2019s syndrome. Polysomnographic and neuropathological study","volume":"23","author":"Kurihara","year":"1992","journal-title":"Neuropediatrics"},{"issue":"1","key":"10.1016\/j.ymgme.2024.108507_bb0370","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s13023-016-0471-6","article-title":"Causes of death and clinical characteristics of 34 patients with Mucopolysaccharidosis II in Taiwan from 1995-2012","volume":"11","author":"Lin","year":"2016","journal-title":"Orphanet J. Rare Dis."},{"issue":"6","key":"10.1016\/j.ymgme.2024.108507_bb0375","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s10545-017-0075-x","article-title":"Survival in idursulfase-treated and untreated patients with mucopolysaccharidosis type II: data from the Hunter Outcome Survey (HOS)","volume":"40","author":"Burton","year":"2017","journal-title":"J. Inherit. Metab. Dis."},{"issue":"8","key":"10.1016\/j.ymgme.2024.108507_bb0380","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.braindev.2021.04.003","article-title":"Mucolipidosis II and III with neurological symptoms due to spinal cord compression","volume":"43","author":"Nakaoka","year":"2021","journal-title":"Brain and Development"},{"key":"10.1016\/j.ymgme.2024.108507_bb0385","doi-asserted-by":"crossref","first-page":"1103620","DOI":"10.3389\/fgene.2023.1103620","article-title":"Phenotypic and genetic characteristics of 130 patients with mucopolysaccharidosis type II: a single-center retrospective study in China","volume":"14","author":"Zhang","year":"2023","journal-title":"Front. Genet."},{"issue":"4","key":"10.1016\/j.ymgme.2024.108507_bb0390","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1159\/000346842","article-title":"Mucopolysaccharidosis type II and the G374sp mutation","volume":"4","author":"Mart\u00ednez-Quintana","year":"2013","journal-title":"Mol Syndromol."},{"issue":"1","key":"10.1016\/j.ymgme.2024.108507_bb0395","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13023-018-0827-1","article-title":"Clinical characteristics and surgical history of Taiwanese patients with mucopolysaccharidosis type II: data from the Hunter outcome survey (HOS)","volume":"13","author":"Lin","year":"2018","journal-title":"Orphanet J. Rare Dis."},{"issue":"2","key":"10.1016\/j.ymgme.2024.108507_bb0400","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ymgme.2019.07.016","article-title":"Ten years of enzyme replacement therapy in paediatric onset mucopolysaccharidosis II in England","volume":"129","author":"Broomfield","year":"2020","journal-title":"Mol. Genet. Metab."},{"issue":"1","key":"10.1016\/j.ymgme.2024.108507_bb0405","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s12890-020-1143-9","article-title":"Case report of endoprosthesis -Y implantation in severe respiratory failure in the MPSII patient; comparison with literature data","volume":"20","author":"Gocyk","year":"2020","journal-title":"BMC Pulm. Med."},{"issue":"5","key":"10.1016\/j.ymgme.2024.108507_bb0410","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/ped.14467","article-title":"Clinical assessment of upper airway and its complications in Hunter syndrome","volume":"63","author":"Iijima","year":"2021","journal-title":"Pediatr. Int."},{"issue":"5","key":"10.1016\/j.ymgme.2024.108507_bb0415","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1023\/A:1005525931994","article-title":"Long-term follow-up following bone marrow transplantation for Hunter disease","volume":"22","author":"Vellodi","year":"1999","journal-title":"J. Inherit. Metab. Dis."},{"issue":"1","key":"10.1016\/j.ymgme.2024.108507_bb0420","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3390\/diagnostics10010037","article-title":"Laryngeal, tracheal, and bronchial disease in the mucopolysaccharidoses: endoscopic study","volume":"10","author":"Pires de Mello","year":"2020","journal-title":"Diagnostics (Basel)."},{"issue":"1","key":"10.1016\/j.ymgme.2024.108507_bb0425","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/ajmg.a.34371","article-title":"Retrospective analysis of the clinical manifestations and survival of Korean patients with mucopolysaccharidosis type II: emphasis on the cardiovascular complication and mortality cases","volume":"158A","author":"Sohn","year":"2012","journal-title":"Am. J. Med. Genet. A"},{"issue":"9","key":"10.1016\/j.ymgme.2024.108507_bb0430","article-title":"A phase II\/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome). Genet Med. 2006. 8(8): p. 465\u201373. doi: 10.1097\/01.gim.0000232477.37660.fb","volume":"8","author":"Muenzer","year":"2006","journal-title":"Erratum in: Genet. Med."},{"issue":"10","key":"10.1016\/j.ymgme.2024.108507_bb0435","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/clc.4960111014","article-title":"Severe aortic stenosis in systemic lupus erythematosus and mucopolysaccharidosis type II (Hunter\u2019s syndrome)","volume":"11","author":"Zimmermann","year":"1988","journal-title":"Clin. Cardiol."},{"issue":"2","key":"10.1016\/j.ymgme.2024.108507_bb0440","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S1054-8807(01)00099-0","article-title":"Left ventricular aneurysm, aortic valve disease and coronary narrowing in a patient with Hunter\u2019s syndrome","volume":"11","author":"Kettles","year":"2002","journal-title":"Cardiovasc. Pathol."},{"issue":"2","key":"10.1016\/j.ymgme.2024.108507_bb0445","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S0022-3476(00)70117-X","article-title":"Sudden death in Hunter syndrome caused by complete atrioventricular block","volume":"136","author":"Hishitani","year":"2000","journal-title":"J. Pediatr."},{"issue":"10","key":"10.1016\/j.ymgme.2024.108507_bb0450","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/sj.bmt.1702397","article-title":"Unrelated umbilical cord blood transplantation in infancy for mucopolysaccharidosis type IIB (Hunter syndrome) complicated by autoimmune hemolytic anemia","volume":"25","author":"Mullen","year":"2000","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.ymgme.2024.108507_bb0455","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJM195908202610804","article-title":"Pulmonary disability in the hurler syndrome (lipochondrodystrophy): a study of two cases","volume":"261","author":"Murray","year":"1959","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.ymgme.2024.108507_bb0460","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ymgme.2009.08.006","article-title":"Japan Elaprase treatment (JET) study: idursulfase enzyme replacement therapy in adult patients with attenuated Hunter syndrome (Mucopolysaccharidosis II, MPS II)","volume":"99","author":"Okuyama","year":"2010","journal-title":"Mol. Genet. Metab."},{"issue":"6","key":"10.1016\/j.ymgme.2024.108507_bb0465","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/j.1399-3046.2007.00876.x","article-title":"Umbilical cord-blood transplantations from unrelated donors in patients with inherited metabolic diseases: single-institute experience","volume":"12","author":"Tokimasa","year":"2008","journal-title":"Pediatr. Transplant."},{"issue":"3","key":"10.1016\/j.ymgme.2024.108507_bb0470","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ymgme.2009.05.006","article-title":"Localized donor cells in brain of a Hunter disease patient after cord blood stem cell transplantation","volume":"98","author":"Araya","year":"2009","journal-title":"Mol. Genet. Metab."},{"issue":"5","key":"10.1016\/j.ymgme.2024.108507_bb0475","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/s00381-018-3998-0","article-title":"Surgical consideration in Hunter syndrome: a case of hydrocephalus and a case of epidural hematoma","volume":"35","author":"Li","year":"2019","journal-title":"Childs Nerv. Syst."},{"key":"10.1016\/j.ymgme.2024.108507_bb0480","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinsp.2022.100082","article-title":"Impact of ERT and follow-up of 17 patients from the same family with a mild form of MPS II","volume":"77","author":"Stephan","year":"2022","journal-title":"Clinics (Sao Paulo)"},{"key":"10.1016\/j.ymgme.2024.108507_bb0485","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/8904_2011_90","article-title":"Report of a large Brazilian family with a very attenuated form of Hunter syndrome (MPS II)","volume":"4","author":"Quaio","year":"2012","journal-title":"JIMD Rep."},{"issue":"6","key":"10.1016\/j.ymgme.2024.108507_bb0490","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1007\/BF02429071","article-title":"Normal excretion of urinary acid mucopolysaccharides in a boy with iduronate sulphatase deficiency, Hunter phenotype and alpha 1-antitrypsin deficiency","volume":"145","author":"Nielsen","year":"1986","journal-title":"Eur. J. Pediatr."},{"issue":"2","key":"10.1016\/j.ymgme.2024.108507_bb0495","first-page":"187","article-title":"Hunter syndrome (Muccopolysaccharridosis type II) in Macedonia and Bulgaria","volume":"32","author":"Gucev","year":"2011","journal-title":"Prilozi"},{"issue":"3","key":"10.1016\/j.ymgme.2024.108507_bb0500","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.ymgme.2012.08.013","article-title":"Effect of rapid cessation of enzyme replacement therapy: a report of 5 cases and a review of the literature","volume":"107","author":"Jurecka","year":"2012","journal-title":"Mol. Genet. Metab."},{"issue":"455","key":"10.1016\/j.ymgme.2024.108507_bb0505","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1651-2227.2007.00212.x","article-title":"A clinical study of 77 patients with mucopolysaccharidosis type II","volume":"96","author":"Schwartz","year":"2007","journal-title":"Acta Paediatr."},{"issue":"2","key":"10.1016\/j.ymgme.2024.108507_bb0510","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2011.01.054","article-title":"Prevalence and characterization of cardiac involvement in Hunter syndrome","volume":"159","author":"Kampmann","year":"2011","journal-title":"J. Pediatr."},{"issue":"4","key":"10.1016\/j.ymgme.2024.108507_bb0515","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1469-8749.1983.tb13794.x","article-title":"The natural history of the severe form of Hunter\u2019s syndrome: a study based on 52 cases","volume":"25","author":"Young","year":"1983","journal-title":"Dev. Med. Child Neurol."},{"issue":"11","key":"10.1016\/j.ymgme.2024.108507_bb0520","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1136\/adc.57.11.828","article-title":"Mild form of Hunter\u2019s syndrome: clinical delineation based on 31 cases","volume":"57","author":"Young","year":"1982","journal-title":"Arch. Dis. Child."},{"issue":"4","key":"10.1016\/j.ymgme.2024.108507_bb0525","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1365-2214.1981.tb00838.x","article-title":"Psychosocial problems in Hunter\u2019s syndrome","volume":"7","author":"Young","year":"1981","journal-title":"Child Care Health Dev."},{"key":"10.1016\/j.ymgme.2024.108507_bb0530","first-page":"269","article-title":"Mucopolysaccharidoses","volume":"33","author":"Muenzer","year":"1986","journal-title":"Adv. Pediatr. Infect. Dis."},{"issue":"2","key":"10.1016\/j.ymgme.2024.108507_bb0535","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1017\/S0022215115003357","article-title":"Alterations of mucosa of the larynx and hypopharynx in patients with mucopolysaccharidoses","volume":"130","author":"Keilmann","year":"2016","journal-title":"J. Laryngol. Otol."},{"issue":"3","key":"10.1016\/j.ymgme.2024.108507_bb0540","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/ped.12636","article-title":"Sanfilippo syndrome: Overall review","volume":"57","author":"Andrade","year":"2015","journal-title":"Pediatr. Int."},{"issue":"1","key":"10.1016\/j.ymgme.2024.108507_bb0545","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13023-018-0796-4","article-title":"Epidemiology of Sanfilippo syndrome: results of a systematic literature review","volume":"13","author":"Zelei","year":"2018","journal-title":"Orphanet J. Rare Dis."},{"issue":"2","key":"10.1016\/j.ymgme.2024.108507_bb0550","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s10545-008-0838-5","article-title":"Sanfilippo syndrome: a mini-review","volume":"31","author":"Valstar","year":"2008","journal-title":"J. Inherit. Metab. Dis."},{"issue":"1","key":"10.1016\/j.ymgme.2024.108507_bb0555","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/ajmg.a.33779","article-title":"Incidence and natural history of mucopolysaccharidosis type III in France and comparison with United Kingdom and Greece","volume":"155A","author":"H\u00e9ron","year":"2011","journal-title":"Am. J. Med. Genet. A"},{"issue":"12","key":"10.1016\/j.ymgme.2024.108507_bb0560","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1136\/adc.2004.065482","article-title":"Sleep disturbance in Sanfilippo syndrome: a parental questionnaire study","volume":"90","author":"Fraser","year":"2005","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.ymgme.2024.108507_bb0565","series-title":"GeneReviews\u00ae [Internet]","article-title":"Mucopolysaccharidosis Type III","author":"Wagner","year":"2019"},{"issue":"2","key":"10.1016\/j.ymgme.2024.108507_bb0570","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ymgme.2007.09.011","article-title":"Clinical and genetic spectrum of Sanfilippo type C (MPS IIIC) disease in the Netherlands","volume":"93","author":"Ruijter","year":"2008","journal-title":"Mol. Genet. Metab."},{"issue":"6","key":"10.1016\/j.ymgme.2024.108507_bb0575","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1002\/ana.22092","article-title":"Mucopolysaccharidosis type IIIA: clinical spectrum and genotype-phenotype correlations","volume":"68","author":"Valstar","year":"2010","journal-title":"Ann. Neurol."},{"issue":"9","key":"10.1016\/j.ymgme.2024.108507_bb0580","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1002\/ajmg.a.40351","article-title":"Mucopolysaccharidosis III in Taiwan: natural history, clinical and molecular characteristics of 28 patients diagnosed during a 21-year period","volume":"176","author":"Lin","year":"2018","journal-title":"Am. J. Med. Genet. A"},{"issue":"1","key":"10.1016\/j.ymgme.2024.108507_bb0585","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s13023-017-0717-y","article-title":"Mortality in patients with Sanfilippo syndrome","volume":"12","author":"Lavery","year":"2017","journal-title":"Orphanet J. Rare Dis."},{"issue":"6","key":"10.1016\/j.ymgme.2024.108507_bb0590","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s10545-010-9199-y","article-title":"Mucopolysaccharidosis type IIIB may predominantly present with an attenuated clinical phenotype","volume":"33","author":"Valstar","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"issue":"5","key":"10.1016\/j.ymgme.2024.108507_bb0595","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s00401-007-0325-3","article-title":"Mechanisms of neurodegeneration in mucopolysaccharidoses II and IIIB: analysis of human brain tissue","volume":"115","author":"Hamano","year":"2008","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ymgme.2024.108507_bb0600","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/1750-1172-8-189","article-title":"Natural history of Sanfilippo syndrome in Spain","volume":"8","author":"Delgadillo","year":"2013","journal-title":"Orphanet J. Rare Dis."},{"issue":"2","key":"10.1016\/j.ymgme.2024.108507_bb0605","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.bbmt.2005.11.384","article-title":"Neurobehavioral outcome in children with MPS III (Sanfilippo syndrome) after unrelated donor umbilical cord blood transplantation (UCBT)","volume":"12","author":"Escolar","year":"2006","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"2","key":"10.1016\/j.ymgme.2024.108507_bb0610","first-page":"S82","article-title":"Coronary artery disease in non-hurler mucopolysaccharidosis","volume":"108","author":"Schroeder","year":"2013","journal-title":"Mol. Genet. Metab."},{"issue":"11","key":"10.1016\/j.ymgme.2024.108507_bb0615","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1111\/j.1651-2227.2008.00965.x","article-title":"Mucopolysaccharidoses in the Scandinavian countries: incidence and prevalence","volume":"97","author":"Malm","year":"2008","journal-title":"Acta Paediatr."},{"issue":"1","key":"10.1016\/j.ymgme.2024.108507_bb0620","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0194-5998(98)70371-7","article-title":"Otologic and laryngologic manifestations of mucopolysaccharidoses after bone marrow transplantation","volume":"118","author":"Papsin","year":"1998","journal-title":"Otolaryngol. Head Neck Surg."},{"issue":"2","key":"10.1016\/j.ymgme.2024.108507_bb0625","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.prrv.2010.10.005","article-title":"Respiratory manifestations in mucopolysaccharidoses","volume":"12","author":"Muhlebach","year":"2011","journal-title":"Paediatr. Respir. Rev."},{"issue":"1","key":"10.1016\/j.ymgme.2024.108507_bb0630","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jcrc.2014.07.011","article-title":"Aspiration pneumonia: a review of modern trends","volume":"30","author":"DiBardino","year":"2015","journal-title":"J. Crit. Care"},{"issue":"10","key":"10.1016\/j.ymgme.2024.108507_bb0635","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.amjhyper.2005.04.020","article-title":"Reduction of pneumonia risk by an angiotensin I-converting enzyme inhibitor in elderly Japanese inpatients according to insertion\/deletion polymorphism of the angiotensin I-converting enzyme gene","volume":"18","author":"Takahashi","year":"2005","journal-title":"Am. J. Hypertens."},{"issue":"2","key":"10.1016\/j.ymgme.2024.108507_bb0640","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jamda.2007.10.003","article-title":"Reducing the risk of aspiration pneumonia among elderly patients in long-term care facilities through oral health interventions","volume":"9","author":"Sarin","year":"2008","journal-title":"J. Am. Med. Dir. Assoc."},{"issue":"9193","key":"10.1016\/j.ymgme.2024.108507_bb0645","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1016\/S0140-6736(98)12251-1","article-title":"Supine body position as a risk factor for nosocomial pneumonia in mechanically ventilated patients: a randomised trial","volume":"354","author":"Drakulovic","year":"1999","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.ymgme.2024.108507_bb0650","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1164\/rccm.200212-1543OC","article-title":"Microbiology of severe aspiration pneumonia in institutionalized elderly","volume":"167","author":"El-Solh","year":"2003","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.ymgme.2024.108507_bb0655","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1378\/chest.115.1.178","article-title":"The role of anaerobes in patients with ventilator-associated pneumonia and aspiration pneumonia: a prospective study","volume":"115","author":"Marik","year":"1999","journal-title":"Chest"},{"issue":"1\u20132","key":"10.1016\/j.ymgme.2024.108507_bb0660","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1159\/000064674","article-title":"Cardiac structural involvement in mucopolysaccharidoses","volume":"98","author":"Rigante","year":"2002","journal-title":"Cardiology"},{"issue":"4","key":"10.1016\/j.ymgme.2024.108507_bb0665","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.ymgme.2014.02.009","article-title":"Cardiovascular abnormalities in Taiwanese patients with mucopolysaccharidosis","volume":"111","author":"Lin","year":"2014","journal-title":"Mol. Genet. Metab."},{"issue":"1","key":"10.1016\/j.ymgme.2024.108507_bb0670","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/s13023-022-02396-5","article-title":"Cardiac involvement in MPS patients: incidence and response to therapy in an Italian multicentre study","volume":"17","author":"Sestito","year":"2022","journal-title":"Orphanet J. Rare Dis."},{"issue":"7","key":"10.1016\/j.ymgme.2024.108507_bb0675","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1007\/s004310050872","article-title":"Cardiovascular changes in children with mucopolysaccharide storage diseases and related disorders--clinical and echocardiographic findings in 64 patients","volume":"157","author":"Dangel","year":"1998","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.ymgme.2024.108507_bb0680","doi-asserted-by":"crossref","first-page":"195","DOI":"10.4274\/jpr.galenos.2021.65768","article-title":"Evaluation of cardiac findings in mucopolysaccharidosis type III patients","volume":"8","author":"Bilginer G\u00fcrb\u00fcz","year":"2021","journal-title":"J Pediatr Res."},{"issue":"2","key":"10.1016\/j.ymgme.2024.108507_bb0685","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/BF00796996","article-title":"Severe mitral insufficiency in mucopolysaccharidosis type III-B (Sanfilippo syndrome)","volume":"14","author":"Muenzer","year":"1993","journal-title":"Pediatr. Cardiol."},{"issue":"1\u20132","key":"10.1016\/j.ymgme.2024.108507_bb0690","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ymgme.2016.11.007","article-title":"Mucopolysaccharidosis IVA and glycosaminoglycans","volume":"120","author":"Khan","year":"2017","journal-title":"Mol. Genet. Metab."},{"issue":"7","key":"10.1016\/j.ymgme.2024.108507_bb0695","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.bbadis.2011.03.018","article-title":"GM1 gangliosidosis and Morquio B disease: an update on genetic alterations and clinical findings","volume":"1812","author":"Caciotti","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"issue":"5 Suppl","key":"10.1016\/j.ymgme.2024.108507_bb0700","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/j.jpeds.2004.01.052","article-title":"The mucopolysaccharidoses: a heterogeneous group of disorders with variable pediatric presentations","volume":"144","author":"Muenzer","year":"2004","journal-title":"J. Pediatr."},{"issue":"1","key":"10.1016\/j.ymgme.2024.108507_bb0705","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/s13023-021-01880-8","article-title":"Epidemiology of mucopolysaccharidoses (MPS) in United States: challenges and opportunities","volume":"16","author":"Puckett","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"issue":"2","key":"10.1016\/j.ymgme.2024.108507_bb0710","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s10545-007-0529-7","article-title":"International Morquio A registry: clinical manifestation and natural course of Morquio A disease","volume":"30","author":"Monta\u00f1o","year":"2007","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2024.108507_bb0715","series-title":"GeneReviews\u00ae [Internet]","article-title":"Mucopolysaccharidosis Type IVA. 2013 Jul 11 [Updated 2021 Jun 17]","author":"Regier","year":"1993"},{"key":"10.1016\/j.ymgme.2024.108507_bb0720","first-page":"59","article-title":"Mortality in patients with morquio syndrome a","volume":"15","author":"Lavery","year":"2015","journal-title":"JIMD Rep."},{"issue":"9","key":"10.1016\/j.ymgme.2024.108507_bb0725","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1080\/21678707.2016.1214572","article-title":"Current therapies for Morquio A syndrome and their clinical outcomes","volume":"4","author":"Sawamoto","year":"2016","journal-title":"Expert Opin. Orphan Drugs"},{"key":"10.1016\/j.ymgme.2024.108507_bb0730","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1186\/s13023-020-01545-y","article-title":"Clinical characteristics of patients from Quebec, Canada, with Morquio A syndrome: a longitudinal observational study","volume":"15","author":"Moisan","year":"2020","journal-title":"Orphanet J. Rare Dis."},{"issue":"3","key":"10.1016\/j.ymgme.2024.108507_bb0735","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1159\/000518443","article-title":"Increased choroidal thickness in Morquio syndrome","volume":"12","author":"Magalh\u00e3es","year":"2021","journal-title":"Case Rep Ophthalmol."},{"issue":"4","key":"10.1016\/j.ymgme.2024.108507_bb0740","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/BF00920060","article-title":"Ocular histopathology and ultrastructure of Morquio syndrome (systemic mucopolysaccharidosis IV A)","volume":"228","author":"Iwamoto","year":"1990","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.ymgme.2024.108507_bb0745","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1750-1172-9-21","article-title":"Natural history and clinical assessment of Taiwanese patients with mucopolysaccharidosis IVA","volume":"9","author":"Lin","year":"2014","journal-title":"Orphanet J. Rare Dis."},{"issue":"1","key":"10.1016\/j.ymgme.2024.108507_bb0750","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00432778","article-title":"Coronary intimal sclerosis in Morquio\u2019s syndrome","volume":"379","author":"Factor","year":"1978","journal-title":"Virchows Arch. A Pathol. Anat. Histol."},{"issue":"3","key":"10.1016\/j.ymgme.2024.108507_bb0755","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ymgme.2013.04.009","article-title":"Pathogenesis of Morquio A syndrome: an autopsied case reveals systemic storage disorder","volume":"109","author":"Yasuda","year":"2013","journal-title":"Mol. Genet. Metab."},{"issue":"Suppl. 2","key":"10.1016\/j.ymgme.2024.108507_bb0760","article-title":"The Eighteenth Annual Meeting of the European Association of Echocardiography","volume":"15","year":"2014","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"issue":"4","key":"10.1016\/j.ymgme.2024.108507_bb0765","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s002470050131","article-title":"Lumbar gibbus in storage diseases and bone dysplasias","volume":"27","author":"Levin","year":"1997","journal-title":"Pediatr. Radiol."},{"issue":"2","key":"10.1016\/j.ymgme.2024.108507_bb0770","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ymgme.2015.09.011","article-title":"Hematopoietic stem cell transplantation for Morquio A syndrome","volume":"117","author":"Yabe","year":"2016","journal-title":"Mol. Genet. Metab."},{"issue":"4","key":"10.1016\/j.ymgme.2024.108507_bb0775","doi-asserted-by":"crossref","first-page":"e329","DOI":"10.1016\/j.athoracsur.2016.02.113","article-title":"Surgical reconstruction for severe tracheal obstruction in Morquio A syndrome","volume":"102","author":"Pizarro","year":"2016","journal-title":"Ann. Thorac. Surg."},{"issue":"2","key":"10.1016\/j.ymgme.2024.108507_bb0780","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ymgme.2015.09.007","article-title":"Obstructive airway in Morquio A syndrome, the past, the present and the future","volume":"117","author":"Tomatsu","year":"2016","journal-title":"Mol. Genet. Metab."},{"issue":"3","key":"10.1016\/j.ymgme.2024.108507_bb0785","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/BF01799267","article-title":"Mucopolysaccharidosis type IVA (Morquio syndrome): a clinical review","volume":"19","author":"Northover","year":"1996","journal-title":"J. Inherit. Metab. Dis."},{"issue":"2","key":"10.1016\/j.ymgme.2024.108507_bb0790","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s10545-013-9586-2","article-title":"Spinal involvement in mucopolysaccharidosis IVA (Morquio-Brailsford or Morquio A syndrome): presentation, diagnosis and management","volume":"36","author":"Solanki","year":"2013","journal-title":"J. Inherit. Metab. Dis."},{"issue":"10","key":"10.1016\/j.ymgme.2024.108507_bb0795","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1001\/archotol.1990.01870100099022","article-title":"Management of tracheal lesions in hurler syndrome","volume":"116","author":"Adachi","year":"1990","journal-title":"Arch. Otolaryngol. Head Neck Surg."},{"issue":"1","key":"10.1016\/j.ymgme.2024.108507_bb0800","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1001\/archoto.2008.515","article-title":"Airway management in children with mucopolysaccharidoses","volume":"135","author":"Yeung","year":"2009","journal-title":"Arch. Otolaryngol. Head Neck Surg."},{"issue":"3","key":"10.1016\/j.ymgme.2024.108507_bb0805","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0165-5876(86)80034-9","article-title":"Upper airway obstruction in Hunter syndrome","volume":"11","author":"Brama","year":"1986","journal-title":"Int. J. Pediatr. Otorhinolaryngol."},{"issue":"9","key":"10.1016\/j.ymgme.2024.108507_bb0810","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1111\/j.1460-9592.2012.03904.x","article-title":"Anesthetic care and perioperative complications of children with Morquio syndrome","volume":"22","author":"Theroux","year":"2012","journal-title":"Paediatr. Anaesth."},{"issue":"6","key":"10.1016\/j.ymgme.2024.108507_bb0815","doi-asserted-by":"crossref","first-page":"931","DOI":"10.2174\/138920111795542615","article-title":"Mucopolysaccharidosis type IVA (Morquio A disease): clinical review and current treatment","volume":"12","author":"Tomatsu","year":"2011","journal-title":"Curr. Pharm. Biotechnol."},{"issue":"9","key":"10.1016\/j.ymgme.2024.108507_bb0820","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0162612","article-title":"Heart and cardiovascular involvement in patients with mucopolysaccharidosis type IVA (Morquio-A syndrome)","volume":"11","author":"Kampmann","year":"2016","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.ymgme.2024.108507_bb0825","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/0002-8703(87)90666-1","article-title":"Heart rate and cardiovascular mortality: the Framingham study","volume":"113","author":"Kannel","year":"1987","journal-title":"Am. Heart J."},{"issue":"4","key":"10.1016\/j.ymgme.2024.108507_bb0830","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.cpcardiol.2015.01.002","article-title":"Sudden cardiac death","volume":"40","author":"Kuriachan","year":"2015","journal-title":"Curr. Probl. Cardiol."},{"issue":"24","key":"10.1016\/j.ymgme.2024.108507_bb0835","doi-asserted-by":"crossref","first-page":"13456","DOI":"10.3390\/ijms222413456","article-title":"Mucopolysaccharidosis type VI, an updated overview of the disease","volume":"22","author":"D\u2019Avanzo","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymgme.2024.108507_bb0840","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1750-1172-5-5","article-title":"Mucopolysaccharidosis VI","volume":"5","author":"Valayannopoulos","year":"2010","journal-title":"Orphanet J. Rare Dis."},{"issue":"1","key":"10.1016\/j.ymgme.2024.108507_bb0845","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ymgme.2021.02.006","article-title":"Long-term impact of early initiation of enzyme replacement therapy in 34 MPS VI patients: a resurvey study","volume":"133","author":"Horovitz","year":"2021","journal-title":"Mol. Genet. Metab."},{"issue":"5","key":"10.1016\/j.ymgme.2024.108507_bb0850","doi-asserted-by":"crossref","DOI":"10.1111\/petr.12981","article-title":"Non-sibling hematopoietic stem cell transplantation using myeloablative conditioning regimen in children with Maroteaux-Lamy syndrome: a brief report","volume":"21","author":"Behfar","year":"2017","journal-title":"Pediatr. Transplant."},{"key":"10.1016\/j.ymgme.2024.108507_bb0855","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s12687-017-0329-1","article-title":"The clinical and genetic Spectrum of Maroteaux-Lamy syndrome (Mucopolysaccharidosis VI) in the Eastern Province of Saudi Arabia","volume":"9","author":"Al-Sannaa","year":"2018","journal-title":"J Community Genet."},{"key":"10.1016\/j.ymgme.2024.108507_bb0860","first-page":"6","article-title":"Long-term Galsulfase treatment associated with improved survival of patients with mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): 15-year follow-up from the survey study","author":"Quartel","year":"2018","journal-title":"J Inborn Errors Metab Screen."},{"issue":"1","key":"10.1016\/j.ymgme.2024.108507_bb0865","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1161\/01.CIR.85.1.188","article-title":"Valvular heart disease in four patients with Maroteaux-Lamy syndrome","volume":"85","author":"Tan","year":"1992","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.ymgme.2024.108507_bb0870","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1002\/ajmg.a.35905","article-title":"Mucopolysaccharidosis type VI: a predominantly cardiac phenotype associated with homozygosity for p.R152W mutation in the ARSB gene","volume":"161A","author":"Jurecka","year":"2013","journal-title":"Am. J. Med. Genet. A"},{"issue":"3","key":"10.1016\/j.ymgme.2024.108507_bb0875","doi-asserted-by":"crossref","first-page":"183","DOI":"10.5582\/irdr.2017.01036","article-title":"Mucopolysaccharidosis type I, II and VI and response to enzyme replacement therapy: results from a single-center case series study","volume":"6","author":"Franco","year":"2017","journal-title":"Intractable Rare Dis Res."},{"issue":"4","key":"10.1016\/j.ymgme.2024.108507_bb0880","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.ymgme.2011.08.024","article-title":"Mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome) with a predominantly cardiac phenotype","volume":"104","author":"Jurecka","year":"2011","journal-title":"Mol. Genet. Metab."},{"issue":"1","key":"10.1016\/j.ymgme.2024.108507_bb0885","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12881-020-0972-y","article-title":"Mucopolysaccharidosis type VI: case report with first neonatal presentation with ascites fetalis and rapidly progressive cardiac manifestation","volume":"21","author":"Honjo","year":"2020","journal-title":"BMC Med. Genet."},{"issue":"2","key":"10.1016\/j.ymgme.2024.108507_bb0890","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0022-3476(73)80162-3","article-title":"Beta glucuronidase deficiency: report of clinical, radiologic, and biochemical features of a new mucopolysaccharidosis","volume":"82","author":"Sly","year":"1973","journal-title":"J. Pediatr."},{"issue":"6","key":"10.1016\/j.ymgme.2024.108507_bb0895","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1136\/jmedgenet-2015-103322","article-title":"Clinical course of sly syndrome (mucopolysaccharidosis type VII)","volume":"53","author":"Monta\u00f1o","year":"2016","journal-title":"J. Med. Genet."},{"issue":"1","key":"10.1016\/j.ymgme.2024.108507_bb0900","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1159\/000134161","article-title":"Localization by fluorescence in situ hybridization of the human functional beta-glucuronidase gene (GUSB) to 7q11.21 --> q11.22 and two pseudogenes to 5p13 and 5q13","volume":"72","author":"Speleman","year":"1996","journal-title":"Cytogenet. Cell Genet."},{"issue":"1\u20132","key":"10.1016\/j.ymgme.2024.108507_bb0905","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s004399900075","article-title":"The frequency of lysosomal storage diseases in the Netherlands","volume":"105","author":"Poorthuis","year":"1999","journal-title":"Hum. Genet."},{"key":"10.1016\/j.ymgme.2024.108507_bb0910","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1750-1172-7-86","article-title":"Lysosomal storage disorder in non-immunological hydrops fetalis (NIHF): more common than assumed? Report of four cases with transient NIHF and a review of the literature","volume":"7","author":"Whybra","year":"2012","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2024.108507_bb0915","article-title":"MPS VII - extending the classical phenotype","volume":"33","author":"Oldham","year":"2022","journal-title":"Mol Genet Metab Rep."},{"issue":"4","key":"10.1016\/j.ymgme.2024.108507_bb0920","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1080\/13816810.2016.1214973","article-title":"Ocular and electrophysiological findings in a patient with Sly syndrome","volume":"38","author":"Flaherty","year":"2017","journal-title":"Ophthalmic Genet."},{"issue":"5","key":"10.1016\/j.ymgme.2024.108507_bb0925","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.carpath.2015.06.001","article-title":"Cardiovascular pathologies in mucopolysaccharidosis type VII (Sly syndrome)","volume":"24","author":"Gniadek","year":"2015","journal-title":"Cardiovasc. Pathol."},{"issue":"1","key":"10.1016\/j.ymgme.2024.108507_bb0930","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1542\/peds.2008-0416","article-title":"International consensus panel on management and treatment of mucopolysaccharidosis I. Mucopolysaccharidosis I: management and treatment guidelines","volume":"123","author":"Muenzer","year":"2009","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.ymgme.2024.108507_bb0935","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/BF00442197","article-title":"Beta-glucuronidase deficiency in a girl with unusual clinical features","volume":"126","author":"Pfeiffer","year":"1977","journal-title":"Eur. J. Pediatr."},{"issue":"6","key":"10.1016\/j.ymgme.2024.108507_bb0940","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/sj.bmt.1701141","article-title":"Treatment of MPS VII (Sly disease) by allogeneic BMT in a female with homozygous A619V mutation","volume":"21","author":"Yamada","year":"1998","journal-title":"Bone Marrow Transplant."},{"issue":"1","key":"10.1016\/j.ymgme.2024.108507_bb0945","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1186\/s13023-021-01870-w","article-title":"Mucopolysaccharidosis VII in Brazil: natural history and clinical findings","volume":"16","author":"Giugliani","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2024.108507_bb0950","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/8904_2017_43","article-title":"Cardiovascular histopathology of a 11-year old with mucopolysaccharidosis VII demonstrates fibrosis, macrophage infiltration, and arterial luminal stenosis","volume":"39","author":"Lew","year":"2018","journal-title":"JIMD Rep."},{"issue":"5","key":"10.1016\/j.ymgme.2024.108507_bb0955","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/pd.5028","article-title":"Elevation of glycosaminoglycans in the amniotic fluid of a fetus with mucopolysaccharidosis VII","volume":"37","author":"Kubaski","year":"2017","journal-title":"Prenat. Diagn."},{"issue":"Suppl. 2","key":"10.1016\/j.ymgme.2024.108507_bb0960","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s13052-018-0566-x","article-title":"A new case report of severe mucopolysaccharidosis type VII: diagnosis, treatment with haematopoietic cell transplantation and prenatal diagnosis in a second pregnancy","volume":"44","author":"Furlan","year":"2018","journal-title":"Ital. J. Pediatr."},{"issue":"2","key":"10.1016\/j.ymgme.2024.108507_bb0965","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s00439-002-0849-5","article-title":"Mutational analysis in longest known survivor of mucopolysaccharidosis type VII","volume":"112","author":"Storch","year":"2003","journal-title":"Hum. Genet."},{"issue":"1","key":"10.1016\/j.ymgme.2024.108507_bb0970","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jmd2.12039","article-title":"A rare late progression form of Sly syndrome mucopolysaccharidosis","volume":"49","author":"Guffon","year":"2019","journal-title":"JIMD Rep."},{"issue":"2","key":"10.1016\/j.ymgme.2024.108507_bb0975","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1034\/j.1399-0004.2003.00119.x","article-title":"Mucopolysaccharidosis VII: clinical, biochemical and molecular investigation of a Brazilian family","volume":"64","author":"Schwartz","year":"2003","journal-title":"Clin. Genet."},{"issue":"3","key":"10.1016\/j.ymgme.2024.108507_bb0980","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/uog.20371","article-title":"Association between mucopolysaccharidosis type VII and hydrops fetalis","volume":"55","author":"Holtz","year":"2020","journal-title":"Ultrasound Obstet. Gynecol."},{"issue":"7","key":"10.1016\/j.ymgme.2024.108507_bb0985","doi-asserted-by":"crossref","first-page":"e486","DOI":"10.1542\/neo.21-7-e486","article-title":"Case 3: nonimmune hydrops and acute renal failure","volume":"21","author":"Ezhuthachan","year":"2020","journal-title":"Neoreviews"},{"issue":"2","key":"10.1016\/j.ymgme.2024.108507_bb0990","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s10545-012-9563-1","article-title":"Anaesthesia and airway management in mucopolysaccharidosis","volume":"36","author":"Walker","year":"2013","journal-title":"J. Inherit. Metab. Dis."},{"issue":"1","key":"10.1016\/j.ymgme.2024.108507_bb0995","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0002-9149(79)90248-0","article-title":"Quantitation of coronary arterial narrowing at necropsy in sudden coronary death: analysis of 31 patients and comparison with 25 control subjects","volume":"44","author":"Roberts","year":"1979","journal-title":"Am. J. Cardiol."},{"issue":"14","key":"10.1016\/j.ymgme.2024.108507_bb1000","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1056\/NEJM199610033351405","article-title":"Clinical and biochemical manifestations of hyaluronidase deficiency","volume":"335","author":"Natowicz","year":"1996","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.ymgme.2024.108507_bb1005","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1007\/s10545-011-9343-3","article-title":"A complete deficiency of Hyaluronoglucosaminidase 1 (HYAL1) presenting as familial juvenile idiopathic arthritis","volume":"34","author":"Imundo","year":"2011","journal-title":"J. Inherit. Metab. Dis."},{"issue":"2","key":"10.1016\/j.ymgme.2024.108507_bb1010","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1006\/scdb.2000.0244","article-title":"Hyaluronan in morphogenesis","volume":"12","author":"Toole","year":"2001","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.ymgme.2024.108507_bb1015","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/00003086-199002000-00047","article-title":"Hyaluronates in developing skeletal tissues","volume":"251","author":"Nathanson","year":"1990","journal-title":"Clin. Orthop. Relat. Res."},{"key":"10.1016\/j.ymgme.2024.108507_bb1020","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1096\/fasebj.6.7.1563592","article-title":"Hyaluronan","volume":"6","author":"Laurent","year":"1992","journal-title":"FASEB J."},{"issue":"10","key":"10.1016\/j.ymgme.2024.108507_bb1025","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1136\/jmedgenet-2021-108061","article-title":"Novel subtype of mucopolysaccharidosis caused by arylsulfatase K (ARSK) deficiency","volume":"59","author":"Verheyen","year":"2022","journal-title":"J. Med. Genet."},{"issue":"Suppl. 2","key":"10.1016\/j.ymgme.2024.108507_bb1030","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s13052-018-0562-1","article-title":"Enzyme replacement therapy: efficacy and limitations","volume":"44","author":"Concolino","year":"2018","journal-title":"Ital. J. Pediatr."},{"issue":"6","key":"10.1016\/j.ymgme.2024.108507_bb1035","doi-asserted-by":"crossref","first-page":"e1228","DOI":"10.1542\/peds.2008-0999","article-title":"Multidisciplinary management of Hunter syndrome","volume":"124","author":"Muenzer","year":"2009","journal-title":"Pediatrics"},{"issue":"Suppl. 4","key":"10.1016\/j.ymgme.2024.108507_bb1040","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/imj.15100","article-title":"Treatable lysosomal storage diseases in the advent of disease-specific therapy","volume":"50","author":"Peters","year":"2020","journal-title":"Intern. Med. J."},{"key":"10.1016\/j.ymgme.2024.108507_bb1045","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2147\/TACG.S69080","article-title":"Role of elosulfase alfa in mucopolysaccharidosis IVA","volume":"9","author":"Regier","year":"2016","journal-title":"Appl. Clin. Genet."},{"issue":"Suppl. 1","key":"10.1016\/j.ymgme.2024.108507_bb1050","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.pedneo.2022.10.001","article-title":"Current and new therapies for mucopolysaccharidoses","volume":"64","author":"Penon-Portmann","year":"2023","journal-title":"Pediatr. Neonatol."},{"issue":"3","key":"10.1016\/j.ymgme.2024.108507_bb1055","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ymgme.2020.01.003","article-title":"The long-term safety and efficacy of vestronidase alfa, rhGUS enzyme replacement therapy, in subjects with mucopolysaccharidosis VII","volume":"129","author":"Wang","year":"2020","journal-title":"Mol. Genet. Metab."},{"issue":"2\u20133","key":"10.1016\/j.ymgme.2024.108507_bb1060","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1007\/s10545-006-0239-6","article-title":"Limitations of enzyme replacement therapy: current and future","volume":"29","author":"Wraith","year":"2006","journal-title":"J. Inherit. Metab. Dis."},{"issue":"6","key":"10.1016\/j.ymgme.2024.108507_bb1065","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/s10545-014-9715-6","article-title":"Efficacy and safety of enzyme replacement therapy with BMN 110 (elosulfase alfa) for Morquio A syndrome (mucopolysaccharidosis IVA): a phase 3 randomised placebo-controlled study","volume":"37","author":"Hendriksz","year":"2014","journal-title":"J. Inherit. Metab. Dis."},{"issue":"5","key":"10.1016\/j.ymgme.2024.108507_bb1070","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.bbmt.2008.01.009","article-title":"The clinical outcome of hurler syndrome after stem cell transplantation","volume":"14","author":"Aldenhoven","year":"2008","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"7","key":"10.1016\/j.ymgme.2024.108507_bb1075","doi-asserted-by":"crossref","first-page":"e226","DOI":"10.1016\/j.bbmt.2019.02.012","article-title":"Hematopoietic stem cell transplantation for mucopolysaccharidoses: past, present, and future","volume":"25","author":"Taylor","year":"2019","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"11","key":"10.1016\/j.ymgme.2024.108507_bb1080","doi-asserted-by":"crossref","first-page":"5490","DOI":"10.3390\/ijms22115490","article-title":"Gene therapy for mucopolysaccharidosis type II-A review of the current possibilities","volume":"22","author":"Zapolnik","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymgme.2024.108507_bb1085","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.omtm.2021.11.007","article-title":"Promoter considerations in the design of lentiviral vectors for use in treating lysosomal storage diseases","volume":"24","author":"Rintz","year":"2021","journal-title":"Mol Ther Methods Clin Dev."},{"issue":"5990","key":"10.1016\/j.ymgme.2024.108507_bb1090","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/312162a0","article-title":"Transferrin receptor on endothelium of brain capillaries","volume":"312","author":"Jefferies","year":"1984","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.ymgme.2024.108507_bb1095","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s13311-013-0187-4","article-title":"Developing therapeutic antibodies for neurodegenerative disease","volume":"10","author":"Yu","year":"2013","journal-title":"Neurotherapeutics"},{"issue":"9","key":"10.1016\/j.ymgme.2024.108507_bb1100","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/0026-0495(87)90099-0","article-title":"Human blood-brain barrier transferrin receptor","volume":"36","author":"Pardridge","year":"1987","journal-title":"Metabolism"},{"issue":"8","key":"10.1016\/j.ymgme.2024.108507_bb1105","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1038\/mt.2008.119","article-title":"Targeting of the CNS in MPS-IH using a nonviral transferrin-alpha-L-iduronidase fusion gene product","volume":"16","author":"Osborn","year":"2008","journal-title":"Mol. Ther."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719224003913?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719224003913?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T11:41:01Z","timestamp":1720611661000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719224003913"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":221,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S1096719224003913"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2024.108507","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Causes of death in mucopolysaccharidoses","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2024.108507","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108507"}}